About Ablatotech

Our Global Initiative

Our global initiative is focused on developing affordable, portable, stand-alone, ground-breaking devices and kits for the ablation of undesirable tissues such as cancers, non-cancerous tumors, fat, wounds, and genital warts.

A retired teacher in Mahendranagar, Nepal has regained the bounce in his step – literally. His diabetic sores have disappeared after receiving a single treatment, from a community healthcare worker, with a portable Ablatotech ablation device.

It is about to happen; after being so long awaited from Mahendranagar to Detroit.

A 43-year-old woman in the beautiful coastal town of Limbe, in Cameroon, is diagnosed with stage III breast cancer. Her heart races as the young doctor, who hasn’t practiced medicine long enough to tarnish his white coat, reads her pathology report. She has every reason to be worried, because she had witnessed her mother and sister suffer and die from the same type of cancer. The young woman falls to a wooden bench that serves as the examination station and sobs uncontrollably. With a bewildered look the green doctor picks her up and says “Don’t worry; thanks to Ablatotech, we can make that cancer disappear with only two shots and this small device”.

That too is about to happen. The young woman is any patient, around the world, that wants a cancerous tumor to disappear without surgery. She is any patient that wants the tumor to disappear without the debilitating adverse effects and exorbitant costs that are characteristic of current treatments. She is any patient, around the world, that wants a non-cancerous tumor to disappear without surgery. She is any patient, around the world, that wants fat, a wound, or warts to disappear without surgery. At Ablatotech we are developing devices and kits that are going to shift the way modern medicine treats undesirable tissues such as cancers, non-cancerous tumors, fat, wounds, and warts. We are driven by a very strong, profound, and uncompromising zeal to heal the world cheaply and significantly more efficiently.

There are a few things that are fundamental to our global corporate strategy, amongst which are:

  • To develop state-of-the-art devices and kits for the ablation of undesirable tissues, said devices and kits designed to meet the unique challenges of practice at a global scale, especially those presented by developing countries.
  • To develop state-of-the-art devices and kits for the ablation of undesirable tissues, said devices designed to be used as stand-alone devices (without the benefit of other costly devices and/or equipments).
  • To develop affordable, state-of-the-art devices and kits for the ablation of undesirable tissues, and therefore to ensure that our ground-breaking medical treatments are equally available to all persons, in a dignified manner, no matter where in the world they reside.
  • To develop simple, state-of-the-art devices and kits for the ablation of undesirable tissues such that minimally-educated health workers, in the most remote areas of the globe, can easily and rapidly be trained to use these devices to save lives and to improve the quality of human life by alleviating the pain and suffering that is characteristic of undesirable tissues such as cancer, non-cancerous tumors, etc.
  • To develop portable, state-of-the-art devices and kits for the ablation of undesirable tissues, and therefore to ensure that our ground-breaking medical treatments are equally available to all persons, in a dignified manner, no matter where in the world they reside.

 

Our US initiative

Our United States initiative is consistent with our global initiative, except for a diminished emphasis on the development of stand-alone devices. Our corporate strategy for the United States includes the development of affordable, ground-breaking, devices and kits for the ablation of undesirable tissues such as cancers, non-cancerous tumors, fat, wounds, and genital warts.

An oncologist tells a 60-year-old bus driver in Marshall MN that his cancer is inoperable. “Does that mean I’m going to die?” he asks. “No!”, the oncologist replies emphatically, “Thanks to Ablatotech, we can make that tumor disappear with only two shots and this small device”.

Meanwhile, in Pittsburgh PA, a 48-year-old pilot calls his cosmetic surgeon to inquire about liposuction. “Sorry we don’t do that anymore – no one does” the cosmetic surgeon says. “Thanks to Ablatotech, we can make a lot of fat disappear with only two shots and a small device”.

The future of tissue ablation is Ablatotech and it is here. We are ‘futurizing’ the way modern medicine treats unwanted tissues such as cancers, non-cancerous tumors, fat, wounds, and genital warts. We are driven by a profound and uncompromising zeal to heal the world cheaply and more efficiently. It is our position that the current inflationary trend in the cost of healthcare in the United States is unfortunate and unsustainable, and we are therefore, consistent with our global corporate strategy, also using ‘affordability’ and ‘portability’ as  key guiding factors in the development of our devices and kits for the ablation of undesirable tissues for the United States market.

 

What we do

At Ablatotech, we develop technologies for the removal of undesirable tissues, such as cancers, non-cancerous tumors, and fat, that mimic how the body would naturally eliminate these undesirable tissues. It is a vastly better way of treating these undesirable tissues, and we have the technology to do it cheaply.

The current methods of surgical removal of undesirable tissues are long overdue replacements that reflect the state of modern biotechnology – especially methods that remove these undesirable tissues, and alleviate the pain and suffering they cause, by mimicking how the body would naturally remove these undesirable tissues (where applicable). The body primarily removes undesirable tissues by a process called programmed cell death (apoptosis), followed by immune action.

At Ablatotech, we develop technologies for the removal of undesirable tissues in a manner that mimics and enhances the natural removal of undesirable tissues by a healthy body. We trick the undesirable tissues to undergo apoptosis, to commit suicide while releasing signals telling like cells to do same, followed by immune action to clean up the dead and probe the dying undesirable tissue. Our core, patented, technology is ‘Tissue Ablation by Rapid and Sustained Alteration in Membrane Potential’ (TARSAMP).

TARSAMP allows us to ablate undesirable tissues such as cancers, non-cancerous tumors, fat, wounds, and HPV genital warts without adversely interfering in the pathophysiology of the undesirable tissue and by mimicking how the healthy human body removes undesirable tissues. By not adversely interfering with the pathophysiology of the undesirable tissue, as current ablation methods do, TARSAMP ensures a complete removal of the undesirable tissue with minimal adverse effects and, where applicable, a diminished chance of recurrence of the undesirable tissue.

We are on track to develop some of the most significant advances in modern medicine thanks to the smart work of a few scientific adventurers.

George M. Ekema, PhD, JD

President and CEO